Fellowship · Pittsburgh, PA
Sponsored by Allegheny Health Network Medical Education Consortium
PARP Inhibitors in Ovarian Cancer: A Review.
Targeted oncology · 2023 · 162 citations · Thomas Krivak
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Annals of oncology : official journal of the European Society for Medical Oncology · 2021 · 260 citations · John Nakayama
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.
Gynecologic oncology · 2022 · 66 citations · Thomas Krivak
MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive Subtypes.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025 · 10 citations · Thomas Krivak
Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2025 · 11 citations · Eirwen Miller
Same-day Hospital Discharge after Minimally Invasive Hysterectomy in a Gynecologic Oncology Practice: Feasibility, Safety, Predictors of Admission, and Adverse Outcomes.
Journal of minimally invasive gynecology · 2022 · 18 citations · Alyssa Wield
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2025 · 10 citations · Christopher Morse
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
Journal of translational medicine · 2024 · 13 citations · Jenna Zimmerman